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Abstract
Background: Ionizing radiation is used as a therapeutic option in the treatment of certain neoplastic lesions
located, among others, in the pelvic region. The therapeutic doses of radiation employed often result in adverse
effects manifesting themselves primarily in the form of genital tract infections in patients or diarrhea. The data
available in the literature indicate disorders in the microbial ecosystem caused by ionizing radiation, which leads
to the problems mentioned above. In the present study, we examined the influence of ionizing radiation on 52
selected strains of bacteria: Lactobacillus crispatus, L. fermentum, L. plantarum, L. reuteri, L. acidophilus L. amylovorus, L. casei,
L. helveticus, L. paracasei, L. rhamnosus, L. salivarius and L. gasseri. This collection of Lactobacillus bacteria isolates of various
species, obtained from the genital tract and gastrointestinal tract of healthy women, was tested for resistance to
therapeutic doses of ionizing radiation.
Results: The species studied, were isolated from the genital tract (n = 30) and from the anus (n = 22) of healthy
pregnant women. Three doses of 3 Gy (fractionated dose) and 50 Gy (total dose of the whole radiotherapy cycle)
were applied.
The greatest differences in survival of the tested strains in comparison to the control group (not subjected to radiation)
were observed at the dose of 50 Gy. However, the results were not statistically significant. Survival decrease to zero was
not demonstrated for any of the tested strains.
Conclusions: Therapeutic doses of radiation do not affect the Lactobacillus bacteria significantly.
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Background
In 1895, Wilhelm Roentgen discovered X-rays, and as
soon as a year later, in 1896, Émil Grubbé made the first
attempt to employ them in the treatment of breast cancer
[1, 2]. In 1897, the first report appeared describing intestinal
damage resulting from the use of X-rays in radiotherapy
[3], while in 1900 Paul UlrichVilard discovered gamma rays
[4]. Currently, radiotherapy utilizing gamma rays, and
charged particle beams, is permanently present in oncology
as a treatment method for certain types of cancer located,
among others, in the pelvis.
Ionizing radiation, apart from the desired effect, that is
damaging or destruction of cancer cells, also affects the
surrounding normal tissues. With respect to gamma
rays, the interaction with the molecules and cell struc-
tures takes place in an indirect manner [5]. Under the
influence of gamma rays, radiolysis of water occurs with
the formation of reactive oxygen species containing an
unpaired electron in the valence shell. Reactive oxygen
species (ROS) are very reactive because of that and cause
tissue damage through the damage to the DNA chain and
cellular structures [6]. Because the intestinal microbiota
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comprises mainly anaerobic bacteria, ROS is affected by
extremely destructive to their cells. Intestinal ecosystem
disorders may influence on the overall condition of the di-
gestive system. In the event of irradiation of the abdomen
or pelvis, the accompanying clinical symptom may be the
appearance of diarrhea [1, 7, 8] and infections in the female
genital tract [9].
Both the intestines and the vagina are colonized by
bacteria in an abundant way, which significantly cooper-
ate with the host organism to retain its state of homeo-
stasis. The commensal microbiota of the gastrointestinal
tract plays an important role in the process of digestion
and absorption of nutrients as well as it displays the pro-
tection against the invasion of pathogenic microbes by
establishing the resistance to their colonisation and in-
fluencing the host immune system [10]. The number of
bacterial cells inhabiting the human gastrointestinal tract
is growing considering both qualitative and quantitative
aspects starting from the stomach and ending at the
colon. In the stomach there are very few bacteria due to
the low pH of the gastric juice and these are the species
which got there with the digestive tract content and re-
main there for a very short period of time. In the duode-
num and the jejunum the number of bacterial cells
increases and equals approximately 103–104 of bacterial
cells/ml (cfu/ml)-these are mostly representative species
of Streptococcus and Lactobacillus [11]. In the ileum the
number of bacterial cells equals 107–108 cfu/ml and
there is an increase in species diversity [11]. In the whole
large intestine the bacterial population equals about 1014
(i.e., 100 trillion)-in 1 ml of the digestive tract content
the number of the bacterial cells amounts approximately
1011 cfu/ml [12]. The colonic microflora is primarily
composed of anaerobic bacteria (Clostridium, Eubacter-
ium, Bacteroides, Bifidobacterium) and in smaller num-
bers, representatives of aerobic and relatively anaerobic
bacteria (Enterobacteriaceae, Lactobacillus, Streptococcus,
Staphylococcus,) [13]. The vagina is dominated largely by
bacteria of the genus Lactobacillus and, in smaller num-
bers, Bacteroides, Bifidobacterium or Escherichia coli and
Streptococcus [14]. The role of the intestinal flora has been
repeatedly confirmed in the course of many diseases, such
as chronic inflammatory bowel disease (IBD) [15, 16], ir-
ritable bowel syndrome (IBS) [17], allergies [18] or even
metabolic diseases [19]. By analogy, it has been demon-
strated that disorders of the vaginal flora contributed to
the emergence of infections in the reproductive tract. This
concerns mainly the reduction of the population of bac-
teria of the genus Lactobacillus [20, 21].
For many years, research has been carried out on probio-
tics, namely microorganisms (mostly bacterial) exerting
beneficial effects on the host organism. Probiotics primarily
include bacteria of the genus Lactobacillus. A question
arises if, among this significant group of bacteria, there are
strains with varying resistance to radiation at therapeutic
doses applied in patients with tumors of the pelvis and ab-
domen. This is an important issue as it is necessary to
minimize the negative side effects of radiation therapy and
improve the quality of life for patients. In order to do this,
a collection of Lactobacillus bacteria isolates of various
species, obtained from the genital tract and gastrointestinal
tract of healthy women, was tested for resistance to
therapeutic doses of ionizing radiation, equivalent to a
fractionated dose of 3 Gy and a total dose of radiother-
apy throughout the cycle of 50 Gy, which are used in
external beam radiotherapy for cancer.
Results
The collection of 52 bacterial isolates of the species
Lactobacillus were subjected to irradiation at doses of
3 Gy and 50 Gy. The species studied, i.e., L. amylovorus,
L. casei, L. helveticus, L. paracasei, L. rhamnosus, L. sali-
varius and L. gasseri, exhibited a decrease in viability
compared to the control samples; however, the results
were not statistically significant (Fig. 1a). No differences
between the test samples and controls in the average
survival of strains belonging to the following bacterial
species: L. crispatus, L. fermentum, L. plantarum, L. reuteri
and L. acidophilus for the radiation dose of 3 Gy were
showed. When the total dose of 50 Gy was applied, no
change was demonstrated in viability of strains belonging
to two species: L. casei and L. plantarum; in the remaining
cases, bacterial viability decreased compared to control
samples, but the differences were not statistically signifi-
cant (Fig. 1b). A drop in the survival rate to zero was not
found for any of the test strains regardless of the dose of
ionizing radiation applied.
Discussion
Radiation therapy of neoplastic lesions located in the pel-
vis is a commonly used therapeutic method. Ionizing radi-
ation has an effect not only on tumor cells but also affects
normal tissues which is associated with certain symptoms
in patients. Radiation to the pelvic area is most frequently
associated with the occurrence of chronic diarrhea, which
is observed in as many as 80 % of patients [22, 23]. Also,
vaginal flora is altered in women undergoing radiation
therapy, observed through a significant preponderance of
anaerobic bacterial species in these patients. Meanwhile,
the composition of aerobic species does not show signifi-
cant changes in comparison with healthy women [9, 24].
In order to improve the quality of life for patients, the
objective is to mitigate the frequency of bowel movements
through the application of supplementation containing
probiotic bacterial strains. Demers et al. conducted re-
search on 229 patients after irradiation of the pelvis with a
formulation comprising Lactobacillus acidophilus LAC-
361 and Bifidobacterium longum BB-536 and concluded
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that, after 60 days of treatment with the preparation, the
frequency of defecation in the tested patients was reduced
as compared to placebo [22]. Similar observations were
made by Urbancsek et al., and Chitapanarux et al., who
showed that patients supplemented with the preparation
containing Lactobacillus and Bifidobacterium had signifi-
cantly fewer bowel movements than patients receiving
placebo [23, 25]. The literature lacks descriptions of at-
tempts to employ probiotics in the treatment of disorders
of the vaginal flora in women undergoing radiation ther-
apy. The quoted above results of the study prompted us to
attempt to select strains of probiotic bacteria with in-
creased resistance to ionizing radiation at doses applied in
classical radiotherapy of the pelvic area which was the aim
of this study. The test strains were obtained from the geni-
tal tract of healthy pregnant women and were all classified
to the genus Lactobacillus. The two doses of ionizing
radiation applied (3 Gy-fractionated dose) and 50 Gy (total
dose for the full cycle of radiotherapy) did not reduce the
survival of the studied strains in a statistically significant
way, although the dose of 50 Gy was more effective. The
results obtained suggest that therapeutic doses of ionizing
radiation do not significantly affect the survival of bacteria
of the genus Lactobacillus living in the gastrointestinal
tract or the reproductive tract of patients undergoing radi-
ation therapy. Hwanga et al. demonstrated that bacteria
from the genus Lactobacillus reduced their viability to
zero at radiation doses of at least 1000 Gy and higher [26].
Despite this, patients often report difficulty resulting from,
mainly, the occurrence of diarrhea. Possibly, ionizing radi-
ation damages the intestinal epithelium, which enables
direct contact of the intestinal flora with the immune
system of the gastrointestinal tract, which, in turn, leads
to the development of local inflammation and diarrhea
Fig. 1 Average survival of strains within the test species Lactobacillus subjected to ionizing radiation as compared to control: a 3 Gy dose; b 50 Gy dose
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[27, 28]. Inflammation of the gastrointestinal tract conse-
quently induces a change in the quantitative composition
of the individual components of the intestinal flora, which
disrupts the entire intestinal ecosystem and intensifies
gastrointestinal symptoms, which was repeatedly reported
by researchers [12]. If, however, supplementation with pro-
biotic bacteria applied for patients undergoing radiation
therapy brings effects in the form of a reduction in the
number of diarrhea cases [22, 23], then, it may be con-
cluded that there is no need to look for a radioresistant
probiotic strain and it is enough to apply the already fa-
miliar strains, which are already much more resistant
to ionizing radiation than eukaryotic cells.
Conclusions
Therapeutic doses of radiation do not affect the Lactoba-
cillus bacteria significantly, therefore, the described disor-
ders in the composition of the bacterial flora in irradiated
patients may be the result of changes in the host environ-
ment of commensal bacteria.
Methods
Lactobacillus isolates
The 52 isolates examined came from a collection gathered
throughout the year 2010 at the Chair of Microbiology of
the Jagiellonian University Medical College and derived
from routine microbiological diagnostics of the female
genital tract (n = 30) and the anus (n = 22) in healthy preg-
nant women., carried out in our microbiology laboratory.
Inclusion criteria: women between the ages of 18 and
40; pregnant women in the first trimester of gestation
(1st–13th week of gestation); without clinical symptoms
of genitourinary infections, requiring the application of
antibiotherapy; confirmed physiological composition of
genitourinary tract flora according to the 10-point Nugent
score (results: 0–6 value); written permission to take part
in the study.
Exclusion criteria: women under 18 and over 40; preg-
nant women with the so-called high-risk pregnancy; rup-
ture of membranes; gestational diabetes; application of
antibiotherapy in the period of up to 30 days before get-
ting pregnant or during gestation; diagnosis of bacterial
vaginosis, diagnosed on the basis of a direct smear from
a vaginal swab stained with the use of Gram’s method
(results 7–10 points in the 10-point Nugent score) and
on the basis of culture; clinical symptoms of genitouri-
nary infection requiring antibiotherapy; lack of a written
permission to take part in the study.
The study was approved by Jagiellonian University
Bioethical Committee decisions No. KBET/47/B/2009.
Each isolate has been identified to species level by
sequencing 16S rRNA [29]: L. amylovorus (n = 5); L.
casei (n = 3); L. crispatus (n = 10); L. fermentum (n = 3);
L. helveticus (n = 3); L. paracasei (n = 3); L. plantarum
(n = 5); L. reuteri (n = 3); L. rhamnosus (n = 4); L. sali-
varius (n = 3); L. acidophilus (n = 3); L. gasseri (n = 7).
Reference strains
A few reference strains of the genus Lactobacillus were
used in the research: L. fermentum (ATCC 20052); L.
plantarum (ATCC 20174); L. plantarum (ATCC 14431);
L. acidophilus (ATCC 4356).
Bacterial cultures
The tested strains were cultured in anaerobic conditions
at 37 °C for 48 h on de Man-Rogosa-Sharpe MRS agar
(Oxoid).
Preparing strains for irradiation
A 4-ml suspension of 5 McFarland (1,5x109 CFU/ml)
density was prepared in normal saline immediately before
radiation. It was divided into a 2-ml test group (subjected
to radiation) and a 2-ml control. The samples were placed
into plastic Eppendorf tubes.
Irradiation of strains
The test samples placed in a cobalt collimator were irra-
diated at doses of 3 Gy and 50 Gy, corresponding to the
fractionated and total doses (doses added up over the
complete cycle of radiotherapy) used in external beam
radiotherapy for cancer. To irradiate the samples, a
Theratron 780E unit was used containing 60Co source
with an activity of 42.8 TBq for a day of irradiation
emitting quanta of gamma rays of the energy of
1173.237 keV (99 %) and 1332.501 keV (99 %), provided
by the Department of Radiation Physics and Dosimetry
at the Henryk Niewodniczanski Institute of Nuclear
Physics of the Polish Academy of Sciences in Kraków.
Control samples underwent exactly the same procedure
as the test samples, except for undergoing radiotherapy.
Strains viability
The test and control samples were serially diluted in
MRS broth (Oxoid) and plated onto the MRS Agar
(Oxoid). Afterwards, plates were cultured in anaerobic
conditions at 37 °C for 48 h. The cultivated colonies
were counted to determine the number of cells in 1 ml
(CFU/ml).
Statistical analysis
The Mann-Whitney U test was used for analysis of dif-
ferences between the irradiated samples and control
samples within each species. The value p < 0.05 was
regarded as the threshold for statistical significance. All
analyses were conducted using SAS 9.1 package and
SAS Enterprise Quide 3.0 (SAS Institute, USA).
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